Prof Andrew Hattersley’s team brings together researchers working in molecular genetics, human physiology, biochemistry, clinical investigation, and patient care.
Their ground-breaking work in monogenic diabetes (diabetes caused by a change in a single gene) has received over 30 national and international prizes and more than £26M in funding since 2009.